Maria S. Ripa - Publications

Oral Semaglutide and Cardiovascular Outcomes in High-Risk Type 2 Diabetes.

Journal: The New England journal of medicine

Published: March 31, 2025

Effects of oral semaglutide on cardiovascular outcomes in individuals with type 2 diabetes and established atherosclerotic cardiovascular disease and/or chronic kidney disease: Design and baseline characteristics of SOUL, a randomized trial.

Journal: Diabetes, obesity & metabolism

Published: January 13, 2023

Applying REWIND cardiovascular disease criteria to SUSTAIN 6 and PIONEER 6: An exploratory analysis of cardiovascular outcomes with semaglutide.

Journal: Diabetes, obesity & metabolism

Published: November 19, 2020

The effect of glucagon-like peptide-1 receptor agonists liraglutide and semaglutide on cardiovascular and renal outcomes across baseline blood pressure categories: Analysis of the LEADER and SUSTAIN 6 trials.

Journal: Diabetes, obesity & metabolism

Published: March 25, 2020

Clinical characteristics and lipid lowering treatment of patients initiated on proprotein convertase subtilisin-kexin type 9 inhibitors: a nationwide cohort study.

Journal: BMJ open

Published: April 04, 2019

The significance of ST-elevation in aVL in anterolateral myocardial infarction: An assessment by cardiac magnetic resonance imaging.

Journal: Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc

Published: April 22, 2018

Correlation of ST changes in leads V4-V6 to area of ischemia by CMR in inferior STEMI.

Journal: Scandinavian cardiovascular journal : SCJ

Published: March 30, 2018

Correlation of anteroseptal ST elevation with myocardial infarction territories through cardiovascular magnetic resonance imaging.

Journal: Journal of electrocardiology

Published: February 20, 2018

The ECG as decision support in STEMI.

Journal: Danish medical journal

Published: March 03, 2012